A number of other equities analysts also recently issued reports on XRAY. HC Wainwright dropped their price target on DENTSPLY SIRONA from $50.00 to $45.00 and set a “neutral” rating on the stock in a research report on Monday, August 10th. Zacks Investment Research raised DENTSPLY SIRONA from a “sell” rating to a “hold” rating and set a $47.00 price target on the stock in a research report on Monday, August 17th. Bank of America increased their price target on DENTSPLY SIRONA from $54.00 to $56.00 and gave the stock a “buy” rating in a research report on Monday, July 20th. Piper Sandler assumed coverage on DENTSPLY SIRONA in a research report on Tuesday, June 16th. They set an “overweight” rating and a $51.00 price objective on the stock. Finally, Evercore ISI raised DENTSPLY SIRONA from an “in-line” rating to an “outperform” rating and set a $50.00 price objective on the stock in a research report on Wednesday, May 27th. Ten research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and an average price target of $49.13.
XRAY stock opened at $47.39 on Tuesday. DENTSPLY SIRONA has a twelve month low of $31.58 and a twelve month high of $60.87. The company has a quick ratio of 2.38, a current ratio of 3.10 and a debt-to-equity ratio of 0.47. The business’s fifty day simple moving average is $44.54 and its two-hundred day simple moving average is $42.69. The firm has a market cap of $10.35 billion, a price-to-earnings ratio of -206.04, a PEG ratio of 5.06 and a beta of 0.99.
A number of hedge funds and other institutional investors have recently modified their holdings of the business. Schonfeld Strategic Advisors LLC boosted its holdings in DENTSPLY SIRONA by 71.1% in the second quarter. Schonfeld Strategic Advisors LLC now owns 83,133 shares of the medical instruments supplier’s stock worth $3,663,000 after acquiring an additional 34,536 shares in the last quarter. Principal Financial Group Inc. boosted its holdings in DENTSPLY SIRONA by 0.4% in the second quarter. Principal Financial Group Inc. now owns 328,477 shares of the medical instruments supplier’s stock worth $14,473,000 after acquiring an additional 1,268 shares in the last quarter. Ninety One UK Ltd acquired a new stake in DENTSPLY SIRONA in the second quarter worth about $86,156,000. Ninety One SA PTY Ltd acquired a new stake in DENTSPLY SIRONA in the second quarter worth about $29,000. Finally, Handelsbanken Fonder AB purchased a new position in shares of DENTSPLY SIRONA in the second quarter worth about $2,162,000. 96.00% of the stock is owned by institutional investors and hedge funds.
About DENTSPLY SIRONA
DENTSPLY SIRONA Inc designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers.
Further Reading: What is basic economics?
Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.